ProE-NLC has potential anti-breast cancer activity in EAC-bearing mice through multiple interrelated mechanisms including, the elevation of antioxidant status, suppressing angiogenesis, inflammatory and mTOR pathways, and inducing the apoptotic pathway, all of which are a function of increased miRNA-223 expression (Fig. 7). The gene discussed is MTOR; the disease is breast carcinoma.